Search Ontology:
ChEBI

beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-Glcp

Term ID
CHEBI:147065
Synonyms
  • 2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->4)-beta-D-galacto-hexopyranosyl-(1->4)-D-gluco-hexopyranose
  • 2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-D-glucopyranose
  • GlcNAc(b1-4)Gal(b1-4)Glc
  • N-[(2S,3R,4R,5S,6R)-2-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
Definition
An amino trisaccharide consisting of 2-acetamino-2-deoxy-β-D-glucopyranose, β-D-galactopyranose and D-glucopyranose residues joined in sequence by (1→4) glycosidic bonds.
References
  • glygen:G06881DK
  • glytoucan:G06881DK
  • kegg.glycan:G07722
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-Glcp
Phenotype where environments contain beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-Glcp
Phenotype modified by environments containing beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-Glcp
Phenotype affecting beta-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-D-Glcp
Human Disease Model